New Research Shows Leadership Systems — Not People — Are the Bottleneck Productivity is not lost because people lack competence; it is lost because leadership systems do not give supervisors the time, ...

Supporting SMEs in 2026, BDSLCCI introduces new cybersecurity features and governance guidelines for safer business operations. Cybersecurity is essential for every business, regardless of its size, ...

A Values-Driven Deal Focused on Independence, Education, and Community FAIRFAX, VA, UNITED STATES, January 1, 2026 /EINPresswire.com/ — MSP Radio, led by technology analyst and industry educator Dave ...

Utilize AI to analyze application runtime data (e.g., rendering time, communication latency), obtain optimization suggestions (such as reducing component re-rendering, reusing hardware connections), ...

University of Illinois researchers 3D print flat carbon-fiber structures that morph into curved satellite components in space ...

Hypersonic weapons are reshaping modern military competitions. As the U.S. advances its capabilities, understanding the ...

In Part 2 of his story, Benita Albert tells of astronomer Bob Benjamin's career, including teaching and now being a NASA ...

Joshua Rowe Eyler does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

The Department of Education building in Washington, D.C., March 24, 2025. Editorial Fellow Millions of student loan borrowers whose monthly payments were reduced to as low as $0 under a forgiveness ...

In a move that could send millions of student loan borrowers scrambling, the Trump administration announced an agreement on Tuesday to end the SAVE plan, a Biden-era repayment plan that has faced ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...